- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05746195
Optimization of Adaptive Text Messages for Cancer Survivors (OATS II)
Use of Text Messages to Increase Whole Grain Consumption in Colorectal Cancer
Study Overview
Status
Detailed Description
PRIMARY OBJECTIVE:
I. Determine the intervention's feasibility and acceptability.
SECONDARY OBJECTIVES:
I. Estimate the effect of the intervention on the percent of grains consumed that are whole.
II. Estimate the effect of the intervention on total fiber intake (grams per day [g/d]).
EXPLORATORY OBJECTIVE:
I. Assess convergence of the reinforcement learning (RL) algorithm.
OUTLINE:
Patients receive nutrition education materials and then receive the adaptive text message intervention for 12 weeks on study. Patients who are food insecure also receive resources for food banks, information about meal delivery programs, and support for applying for Supplemental Nutrition Assistance Program (SNAP) benefits.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
California
-
San Francisco, California, United States, 94143
- University of California, San Francisco
-
San Francisco, California, United States, 94110
- Zuckerberg San Francisco General
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Age > 18 years.
- Subject has provided informed consent.
- Diagnosis of colon or rectal adenocarcinoma.
- Not on active treatment at the time of screening and not expected to receive active anticancer therapy (e.g., surgery, radiation, chemotherapy) during the study period.
- At least 6 weeks since a major surgery and fully recovered.
- Owns a mobile phone and is willing and able to receive and send text messages.
- Able to speak/read English or Spanish.
- Based on a screening survey, eat grains and =<50% of total grains are whole grains.
Exclusion Criteria:
1. Does not meet any of the above inclusion criteria.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Text message intervention
Adaptive 12-week text message intervention using reinforcement learning to increase whole grain and reduce refined grain intake via the HealthySMS platform.
Participants will also complete semi-structured follow-up interviews and various questionnaires evaluating participants dietary habits and use of study intervention.
|
Text messages will be sent to participants cell phones using the HealthySMS platform
Various questionnaires evaluating participants dietary habits and use of study intervention will be administered
Participants will receive nutrition education materials
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Feasibility of Intervention Measure (FIM)
Time Frame: At 12 weeks
|
The FIM is a four-item measure of implementation that assesses participants perceived appropriateness of the intervention.
Each item response falls on a scale of 1 (Completely disagree) to 5 (Completely agree).
A scaled score is calculated by averaging responses.
Scale values range from 1 to 5. The intervention will be determined acceptable if the overall median score is >= 4.
|
At 12 weeks
|
|
Median Percentage of Text Messages That Participants Responded to That Asked for a Reply
Time Frame: Up to 12 weeks
|
The percentage of text messages responded to is defined as the number of text messages with a response divided by the total number of text messages that ask for a reply and calculated on a per patient basis.
The intervention will be determined feasible if the median response rate (percentage of text messages that participants responded to) across all participants is >= 70%.
|
Up to 12 weeks
|
|
Overall Median Score on the System Usability Scale (SUS)
Time Frame: At 12 weeks
|
The system usability is comprised of 10 questions assessing participants perceived usability of the intervention.
Each item is scored on a scale of 1 (strongly disagree) to 5 ( strongly agree).
The SUS yields a single number representing a composite measure of the overall usability of the text messaging system.
To calculate the SUS score, Each item's score contribution will ultimately range from 0 to 4 (For items 1,3,5,7,and 9 the score contribution is the item score minus 1 and for items 2,4,6,8 and 10, the contribution is the item score minus 5).
The sum of the scores are then multiplied by 2.5 to obtain the overall value.
SUS scores have a range of 0 to 100 with a score > 68 indicating above average usability.
|
At 12 weeks
|
|
Overall Score on the Acceptability of Intervention Measure (AIM)
Time Frame: At 12 weeks
|
The AIM is a four-item measure of implementation that assesses participants perceived acceptability of the intervention.
Each item response falls on a scale of 1 (Completely disagree) to 5 (Completely agree).
A scaled score is calculated by averaging responses.
Scale values range from 1 to 5. The intervention will be determined acceptable if the overall median score is >= 4.
|
At 12 weeks
|
|
Overall Score on the Intervention Appropriateness Measure (IAM)
Time Frame: At 12 weeks
|
The IAM is a four-item measure of implementation that assesses participants perceived appropriateness of the intervention.
Each item response falls on a scale of 1 (Completely disagree) to 5 (Completely agree).
A scaled score is calculated by averaging responses.
Scale values range from 1 to 5. The intervention will be determined acceptable if the overall median score is >= 4.
|
At 12 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Percent of Grains That Are Whole Reported on the Food Frequency Questionnaire (FFQ)
Time Frame: Up to 12 weeks
|
The FFQ will ask about diet in the past 3 months.
For each item, participants will be asked to report how often, on average, they ate the specified portion size in the past 3 months.
Participants can choose from frequency options ranging from never or less than once per month to >=6 times a day.
To compute calorie and nutrient intakes, multiply the frequency of consumption of each food by the amount of each nutrient in the specified portion size using composition values from the U.S. Department of Agriculture and other sources.
Percent of grains that are whole = servings per day of whole grains/(servings per day of refined grains + servings per day of whole grains) will be reported over time
|
Up to 12 weeks
|
|
Change in Mean Total Daily Fiber Intake (Grams Per Day (g/d)) Reported on the Food Frequency Questionnaire (FFQ)
Time Frame: Up to 12 weeks
|
The FFQ will ask about diet in the past 3 months.
For each item, participants will be asked to report how often, on average, they ate the specified portion size in the past 3 months.
Participants can choose from frequency options ranging from never or less than once per month to >=6 times a day.
To compute calorie and nutrient intakes, multiply the frequency of consumption of each food by the amount of each nutrient in the specified portion size using composition values from the U.S. Department of Agriculture and other sources.
The mean total daily fiber intake and standard deviation will be reported over time.
|
Up to 12 weeks
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Erin Van Blarigan, ScD, University of California, San Francisco
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Neoplasms by Site
- Neoplasms
- Intestinal Diseases
- Gastrointestinal Neoplasms
- Digestive System Neoplasms
- Digestive System Diseases
- Gastrointestinal Diseases
- Intestinal Neoplasms
- Rectal Diseases
- Colonic Diseases
- Rectal Neoplasms
- Colorectal Neoplasms
- Colonic Neoplasms
- Health Care Quality, Access, and Evaluation
- Investigative Techniques
- Epidemiologic Methods
- Data Collection
- Health Care Evaluation Mechanisms
- Quality of Health Care
- Public Health
- Environment and Public Health
- Epidemiologic Measurements
- Nutrition Assessment
Other Study ID Numbers
- 224523
- NCI-2023-00870 (Registry Identifier: NCI Clinical Trials Reporting Program (CTRP))
- R21CA263539 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Colorectal Carcinoma
-
National Cancer Institute (NCI)RecruitingStage IV Colorectal Cancer AJCC v8 | Metastatic Microsatellite Stable Colorectal Carcinoma | Refractory Microsatellite Stable Colorectal CarcinomaUnited States
-
Roswell Park Cancer InstituteNational Center for Advancing Translational Sciences (NCATS)RecruitingRecurrent Colorectal Carcinoma | Locally Advanced Colorectal Carcinoma | Stage III Colorectal CancerUnited States
-
National Cancer Institute (NCI)WithdrawnStage IV Colorectal Cancer AJCC v8 | Metastatic Mismatch Repair Proficient Colorectal Carcinoma | Refractory Mismatch Repair Proficient Colorectal CarcinomaUnited States
-
Roswell Park Cancer InstituteWithdrawnPembrolizumab and Autologous Dendritic Cells for the Treatment of Refractory Colorectal Cancer (CRC)Recurrent Colorectal Carcinoma | Stage IV Colorectal Cancer AJCC v8 | Stage III Colorectal Cancer AJCC v8 | Unresectable Colorectal Carcinoma | Metastatic Microsatellite Stable Colorectal CarcinomaUnited States
-
Wuhan Union Hospital, ChinaNot yet recruitingRecurrent Colorectal Carcinoma | Advanced Colorectal CarcinomaChina
-
City of Hope Medical CenterNational Cancer Institute (NCI)Active, not recruitingMetastatic Colorectal Adenocarcinoma | Stage IV Colorectal Cancer AJCC v8 | Stage III Colorectal Cancer AJCC v8 | Metastatic Microsatellite Stable Colorectal Carcinoma | Advanced Microsatellite Stable Colorectal Carcinoma | Advanced Colorectal AdenocarcinomaUnited States
-
Academisch Medisch Centrum - Universiteit van Amsterdam...CompletedColorectal Neoplasms | Colorectal Cancer | Colorectal Adenoma | Colorectal Carcinoma | Colorectal Adenoma and CarcinomaNetherlands
-
Emory UniversityBristol-Myers Squibb; National Cancer Institute (NCI); National Institutes of...CompletedColorectal Cancer Metastatic | Colorectal Adenocarcinoma | Stage IV Colorectal Cancer | Stage IVA Colorectal Cancer | Stage IVB Colorectal Cancer | Refractory Colorectal Carcinoma | Metastatic Microsatellite Stable Colorectal Carcinoma | Stage IVC Colorectal CancerUnited States
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)RecruitingMetastatic Malignant Neoplasm in the Liver | Metastatic Colorectal Carcinoma | Stage IV Colorectal Cancer AJCC v8 | Unresectable Colorectal CarcinomaUnited States
-
Academic and Community Cancer Research UnitedNational Cancer Institute (NCI)CompletedStage IV Colorectal Cancer AJCC v7 | Stage IVA Colorectal Cancer AJCC v7 | Stage IVB Colorectal Cancer AJCC v7 | Recurrent Colorectal Carcinoma | Metastatic Colorectal Carcinoma | Refractory Colorectal CarcinomaUnited States
Clinical Trials on Dietary intervention via Text Messaging
-
Emory UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Georgia... and other collaboratorsCompleted
-
India Diabetes Research Foundation & Dr. A. Ramachandran...Completed
-
Washington University School of MedicineCompletedObesity | Overweight | Severe Mental DisorderUnited States
-
University of MichiganNational Institute on Aging (NIA)Not yet recruitingAging | Physical Inactivity | Behavior Change | Cognitive AbilityUnited States
-
University of Massachusetts, WorcesterNational Institute of Mental Health (NIMH); Yale University; Worcester Polytechnic... and other collaboratorsCompletedMajor Depressive EpisodeUnited States
-
University of WashingtonJohn L. Locke Jr. Charitable TrustTerminatedMyocardial Infarction | Percutaneous Coronary Intervention | Coronary Artery Bypass Surgery | Chronic Stable Angina | Left Ventricular Assist Device | Heart Transplant | Chronic Stable Heart Failure | Heart Valve Repair or ReplacementUnited States
-
University of PennsylvaniaBenefits Data TrustCompletedSocial Determinants of HealthUnited States
-
Jonsson Comprehensive Cancer CenterWithdrawnSurvivors of Childhood CancerUnited States
-
Georgetown UniversityCompleted
-
The University of Hong KongNot yet recruitingIntervention | ControlHong Kong